Capstone Investment Advisors »

Zentalis Pharmaceuticals shares owned by Capstone Investment Advisors

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Capstone Investment Advisors from 13F filings

Historical chart of Capstone Investment Advisors investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Capstone Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $48k 13k 3.68

More positions owned by Capstone Investment Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation Put Option (NVDA)
Apple Put Option (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation Put Option (MSFT)
Meta Platforms Cl A (META)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Amazon Call Option (AMZN)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl C Call Option (GOOG)
Broadcom (AVGO)
Vaneck Etf Trust Gold Miners Etf Call Option (GDX)

View all positions for Capstone Investment Advisors

Top funds holding Zentalis Pharmaceuticals

Matrix Capital Management Company
Eventide Asset Management
Vanguard Group
BlackRock
BlackRock
Decheng Capital
State Street Corporation
Citadel Advisors
Morgan Stanley
PRIMECAP Management Company
MPM Oncology Impact Management
Geode Capital Management
D. E. Shaw & Co
Woodline Partners
Two Sigma Investments

View all funds holding Zentalis Pharmaceuticals